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Regenerative medicine has become an extremely valuable tool offering an alternative to
conventional therapies for the repair and regeneration of tissues. The re-establishment
of tissue and organ functions can be carried out by tissue engineering strategies or
by using medical devices such as implants. However, with any material being implanted
inside the human body, one of the conundrums that remains is the ease with which these
materials can get contaminated by bacteria. Bacterial adhesion leads to the formation
of mature, alive and complex three-dimensional biofilm structures, further infection of
surrounding tissues and consequent development of complicated chronic infections.
Hence, novel tissue engineering strategies delivering biofilm-targeted therapies, while
at the same time allowing tissue formation are highly relevant. In this study our
aim was to develop surface modified polyhydroxyalkanoate-based fiber meshes with
enhanced bacterial anti-adhesive and juvenile biofilm disrupting properties for tissue
regeneration purposes. Using reactive and amphiphilic star-shaped macromolecules
as an additive to a polyhydroxyalkanoate spinning solution, a synthetic antimicrobial
peptide, Amhelin, with strong bactericidal and anti-biofilm properties, and Dispersin
B, an enzyme promoting the disruption of exopolysaccharides found in the biofilm
matrix, were covalently conjugated to the fibers by addition to the solution before
the spinning process. Staphylococcus epidermidis is one of the most problematic
pathogens responsible for tissue-related infections. The initial antibacterial screening
showed that Amhelin proved to be strongly bactericidal at 12 µg/ml and caused >50%
reductions of biofilm formation at 6 µg/ml, while Dispersin B was found to disperse
>70% of pre-formed biofilms at 3 µg/ml. Regarding the cytotoxicity of the agents toward
L929 murine fibroblasts, a CC50 of 140 and 115 µg/ml was measured for Amhelin and
Dispersin B, respectively. Optimization of the electrospinning process resulted in aligned
fibers. Surface activated fibers with Amhelin and Dispersin B resulted in 83% reduction
of adhered bacteria on the surface of the fibers. Additionally, the materials developed
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were found to be cytocompatible toward L929 murine fibroblasts. The strategy reported
in this preliminary study suggests an alternative approach to prevent bacterial adhesion
and, in turn biofilm formation, in materials used in regenerative medicine applications
such as tissue engineering.
Keywords: polyhydroxyalkanoates, Amhelin, Dispersin B, biofilm, electrospinning
INTRODUCTION
Within regenerative medicine applications, the failure of
implantable in situ tissue engineering scaffolds, that should
replace missing or damaged tissue and recruit cells from
the surrounding tissues of the host, bears generally the
probability of bacterial adhesion to its external and internal
surface and subsequent biofilm formation at the time point of
implantation or even later by hematogenous spread. Finally,
this leads to a chronically colonized biomaterial scaffold with
the intrinsic capability to induce an infection at any later
time (Brancatisano et al., 2014; Segev-Zarko et al., 2015;
Batoni et al., 2016).
Biofilms can tolerate various types of physicochemical
treatments including UV light, heavy metals, acidity, changes in
hydration or salinity, and phagocytosis. Additionally, biofilms
typically resist antibiotics even at high concentrations (Lebeaux
et al., 2014). The complexity of the biofilm structure, decreased
growth rates, secretion of enzymes capable of degrading
antibiotics, horizontal gene transfer and communication via
quorum sensing systems are just few of the main factors
involved in the resistance of biofilms against antibiotics (Donlan
and Costerton, 2002; Wi and Patel, 2018). Clearly this leads
to many therapeutic difficulties and most of the times the
solution involves surgical removal of all foreign material
(e.g., medical device, implant or scaffold) and comprehensive
debridement of the infected tissue (Zimmerli and Moser,
2012). This, along with the lack of treatment options against
biofilms, emphasizes the need to develop new locally acting
antibacterial, anti-adhesive and anti-biofilm materials in the
regenerative medicine field.
Tissue formation can be prompted by using polymeric
scaffolds with specific characteristics. For instance, fibrous
polymeric scaffolds are extremely attractive for tissue engineering
applications due to their topographical similarities with the
fibrillae of the extracellular matrix (ECM) and can be produced
using a simple, cost-effective, and versatile approach such as
electrospinning (Repanas et al., 2016).
In terms of the choice of the polymeric material, there
are a variety of natural and synthetic polymers suitable
for the development of tissue engineering scaffolds,
development of medical implants and antimicrobial surfaces.
Polyhydroxyalkanoates (PHAs) are highly biocompatible and
naturally occurring bacteria-derived polyesters and are produced
by bacterial fermentation (Lebeaux et al., 2014; Li et al., 2016).
A variety of PHAs with different properties and degradation rates
can be obtained by changing the conditions of the fermentation
process. Furthermore, PHAs can be processed using several
techniques such as solvent casting, dip molding, 3D printing and
electrospinning, making them attractive candidates for a variety
of medical applications (Reis et al., 2008; Roy and Visakh, 2014).
Regarding the fiber activation against bacteria, it can be done
by covalent attachment of antibacterial agents such as enzymes
and antimicrobial peptides.
Dispersin B (DB) is a 42 kDa glycoside hydrolase
produced by a Gram-negative bacteria Aggregatibacter
actinomycetemcomitans, a human periodontal pathogen.
DB is capable of degrading polysaccharides present in the
biofilm matrix of many bacterial strains, resulting in the
detachment of the bacterial cells (swarming phenotypes)
and their release into the environment. More specifically, it
degrades cationic extracellular polysaccharides, namely β-1,6-
poly-N-acetylglucosamine (PNAG), that work as adhesins
and mediate the attachment of bacteria to abiotic surfaces
(Kaplan, 2009, 2010).
Antimicrobial peptides (AMPs), on the other hand, have been
extensively explored as an alternative to conventional antibiotics
due to their exceptionally broad spectrum of activity against
bacteria, bactericidal efficacy at low concentrations as well as
their multiple modes of action (Onaizi and Leong, 2011). AMPs
vary by size, comprising 10–50 amino-acid residues, net charge,
primary and secondary structures. However, these peptides
also share common characteristics. Most of them are cationic
and fold upon binding to anionic microbial membranes into
amphipathic structures by clustering cationic and hydrophobic
residues in two distinct faces (Ebbensgaard et al., 2015). Because
their action is folding mediated, it can be controlled in a
dose dependent and reversible manner (Ryan et al., 2013).
Once in the membranes, the peptides arrange into membrane-
disrupting pores or channels that destabilize microbial cells,
resulting in cell lysis and death (Powers and Hancock, 2003;
Brogden, 2005; Hancock and Sahl, 2006). One of the reasons
for conventional antibiotics to fail against biofilms is their
inability to target cells with low metabolic activity. Membrane
integrity is essential to bacteria regardless of their metabolic state,
whilst AMPs do not differentiate between dormant, dividing
or mature bacterial cells, killing all. Therefore, the use of
AMPs against cells that are resistant to antibiotics presents
an effective strategy to prevent biofilm formation or treat
established biofilms. However, despite their activity, naturally
occurring AMPs pose some limitations regarding their toxicity
against eukaryotic cells and therefore synthetic AMPs are now
gaining more attention as they can show reduced cytotoxicity
(Steinstraesser et al., 2002). Antimicrobial helix insert (here
termed as Amhelin) is a novel de novo sequence designed
as an archetypal antimicrobial peptide. The peptide folds into
an amphipathic α helix in microbial lipid bilayers where it
forms progressively expanding pores (Rakowska et al., 2013).
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Unlike many AMPs, Amhelin does not cause hemolytic
effects either, with median lethal concentrations (LC50) against
human erythrocytes significantly exceeding the measured CC50
(Ryadnov et al., 2009; Li et al., 2017).
Antimicrobial peptides or enzymes are normally attached to
fiber surfaces post-processing by covalent attachment, which
usually involves several activation steps and includes the use
of chemical cross-linkers. An alternative approach was reported
by Grafahrend et al., where they used an amphiphilic six-
armed star-shaped poly(ethylene oxide-stat-propylene oxide)
containing reactive isocyanate groups at the distal ends of
the polymer chains, NCO-sP(EO-stat-PO), as an additive to
the PLGA spinning solution. The presence of the isocyanate
groups facilitated the covalent coupling of cell adhesion peptides
by addition of these peptides to the spinning solution, thus
resulting in the production of surface-activated fibers in a
single step (Grafahrend et al., 2011). This approach has
recently been used to produce artificial basement-membranes
as a component for the generation of in vitro skin tissue
and expanded for multi-functionalization with peptides and
antibodies for immunomodulatory properties (Wistlich et al.,
2015; Rossi et al., 2016).
In this study, we transferred this strategy to PHAs and
developed PHA-[NCO-sP(EO-stat-PO)] based blend fibers
which we functionalized with membrane targeting Amhelin
and with the biofilm-disrupting enzyme DB. These substrates
allowed us to study the effect of fiber functionalization against
bacterial adhesion and the establishment of predominantly
polysaccharide-based biofilms, such as staphylococcal biofilms,
whilst still allowing for eukaryotic cell attachment. Our
experiments demonstrate that the resulting material combines
anti-adhesive and anti-biofilm properties, and hence holds huge
promise for medical applications.
MATERIALS AND METHODS
Materials
Chemicals, reagents and materials were obtained from Sigma-
Aldrich Company Ltd., (United Kingdom and Germany),
Thermo Fisher Scientific (United Kingdom and Germany),
VWR International (United Kingdom), and Carl Roth
GmbH+ Co., KG (Germany).
Polymers and Antibacterial Agents
Polyhydroxyalkanoates were produced by bacterial fermentation
under nitrogen limiting conditions and with glucose as the
carbon source using Pseudomonas mendocina CH50 at the
Department of Life Sciences in the University of Westminster,
London, United Kingdom.
Amphiphilic six-armed star-shaped poly(ethylene oxide-stat-
propylene oxide) containing reactive isocyanate groups at the
distal ends of the polymer chains, NCO-sP(EO-stat-PO), was
provided by Prof. Jürgen Groll, Department for Functional
Materials in Medicine and Dentistry and Bavarian Polymer
Institute, University of Würzburg, Würzburg, Germany.
Dispersin B was provided by Kane Biotech Inc., (Canada) in
vials containing a buffer solution consisting of 50 mM phosphate
buffer (pH 5.8) with 100mM sodium chloride and 50% glycerol at
a concentration of 475 µg/mL per vial. Amhelin was synthesized
by the National Physical Laboratory (United Kingdom) and was
provided in the form of a lyophilized powder. The peptide was
kept in the freezer, at−20◦C for routine usage.
Bacterial Strains
All antibacterial tests were conducted using the biofilm
forming strain Staphylococcus epidermidis (ATCC R© 35984TM),
purchased from the American Type Culture Collection (ATCC).
The bacterial culture was stored as glycerol stocks in the
freezer, at −20◦C, for routine usage or at −80◦C for longer
storage duration.
The preparation of the inoculum for all antibacterial tests was
done by culturing bacteria overnight on blood agar plates at 37◦C
for 16 h. Using a sterile loop, a single colony was re-suspended
in a glass tube containing 2 mL of 0.9% NaCl and using a
densitometer, the bacterial suspension was adjusted toMcFarland
0.5 (108 CFU/mL). According to each experiment, the bacterial
suspension was further diluted in Mueller-Hinton-Broth (MHB)
to the desired concentration.
Cell Lines and Cell Culture Materials
L929 murine fibroblasts were obtained from DSMZ (German
Collection ofMicroorganisms and Cell Cultures GmbH). Roswell
Park Memorial Institute (RPMI) medium, L-glutamine, 10% fetal
bovine serum and 1% Penicillin-Streptomycin (10.000 U/mL
Penicillin, 10 mg/mL Streptomycin) were obtained from PAN
Biotech (Germany), as well as trypsin 0.25%/1 mM EDTA and
Dulbecco’s Phosphate-Buffered Saline (DPBS) without calcium
andmagnesium. Triton R© X-100 lysis solution andCellTiter-Blue R©
Cell Viability Assay Kit were purchased from Promega. Live/dead
Cell Staining Kit II was purchased from PromoKine.
L929 murine fibroblasts were cultivated in complete Roswell
Park Memorial Institute medium, containing L-glutamine, 10%
fetal bovine serum and 1% Penicillin-Streptomycin (10.000 U/mL
Penicillin, 10 mg/mL Streptomycin) (cRPMI) and maintained
in a humidified atmosphere at 5% CO2 in air at 37
◦C. When
cells reached 70–80% confluency, they were detached using a
trypsin/EDTA solution, collected, and the number of cells was
adjusted in a cell suspension according to each experiment. In
order to avoid variations in cell viability tests, cells were used
until passage 10.
Minimum Inhibitory and Minimum
Bactericidal Concentrations of Amhelin
Against Bacteria
Theminimum inhibitory concentration (MIC) and theminimum
bactericidal concentration (MBC) of Amhelin was determined
against S. epidermidis (ATCC R© 35984TM) according to the
ISO 20776-1:International Organization for Standardization
[ISO], 2006 guidelines in 96 tissue-culture polystyrene (TCPS)
microplates (ISO 20776-1:International Organization for
Standardization [ISO], 2006(E)).
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Briefly, Amhelin was prepared by making a stock solution
of 1 mg/mL in sterile Milli Q water. The stock solution was
further diluted in MHB to a final concentration of 200 µg/mL.
A fresh bacterial suspension of 5 × 105 CFU/mL was prepared
in MHB and serial 2-fold dilutions were prepared by incubating
50 µL of the bacterial suspension with 50 µL of the Amhelin
solution. The plates were incubated at 37◦C for 24 h and the
MIC was determined as the lowest concentration of Amhelin that
completely inhibited bacterial growth by observing the turbidity
of the wells by naked eye. Wells containing 100 µL of MHB
without bacteria were considered as negative controls and wells
containing 100 µL of MHB with bacteria were considered as
the growth controls. The experiments were performed in three
independent experiments, in triplicates (N = 3, n = 3). The MBC
was determined directly after identifying the MIC. For that, the
supernatant of the wells corresponding to the MIC and of three
concentrations above were removed and spread homogeneously
onto blood agar plates with the help of a sterile loop. The
plates were incubated at 37◦C for 24 h. After the incubation
period, the number of colonies were counted and compared
to the number of colonies obtained in the growth controls at
the beginning of the experiment. The MBC was determined as
the lowest concentration of the compound that killed 99.9% or
more of the bacteria, relative to that in the initial inoculum. The
experiments were performed in three independent experiments,
in duplicates (N = 3, n = 2).
Inhibition of Biofilm Formation by
Amhelin
The ability of Amhelin to inhibit biofilm formation was evaluated
by quantifying the amount of biofilm formed after a 24-
hour incubation of bacteria with increasing concentrations of
Amhelin, by adapting the protocol described by Kiran et al.
(2008). Similar to the previous method, serial dilutions of
Amhelin were incubated with a fresh bacterial suspension of
5 × 105 CFU/mL. After a 24-hour incubation period, the
supernatant was entirely removed from the wells and the wells
were carefully washed twice with 100 µL of DPBS and dried
at room temperature. To fix the biofilms, 100 µL of 100%
ethanol were added to each well and the plate was incubated
for 15 minutes at room temperature. The ethanol was removed,
and the biofilms were stained with 100 µL of a 0.1% safranin-O
solution and incubated for 5 min at room temperature followed
by a washing step with 100 µL of DPBS. Finally, the stained
biofilms were re-suspended in 100 µL of 1% sodium dodecyl
sulfate (SDS) and the amount of biofilm was quantified by
measuring the optical density of the dissolved safranin-O at
495 nm (OD495). The experiments were performed in three
independent experiments, in triplicates (N = 3, n = 3).
Dispersion of Pre-established Biofilms
by Dispersin B
The ability of DB to disperse 24-hour pre-formed biofilms was
tested against S. epidermidis (ATCC R© 35984TM) in a 96 well TCPS
microplate according to Marcano et al. (2015).
Each well was loaded with 100 µL of a bacterial suspension
of 5 × 105 CFU/mL and incubated at 37◦C for 24 h. After
this period, the supernatant was carefully removed and filled
with 100 µL of serially diluted concentrations of DB in
MHB and incubated at 37◦C for 24 h. After the incubation
period, the supernatant was removed, and the quantification
of the biofilm biomass was performed as described in section
“Inhibition of Biofilm Formation by Amhelin.” The experiments
were performed in three independent experiments, in triplicates
(N = 3, n = 3).
In vitro Direct Cytotoxicity Evaluation of
Amhelin and Dispersin B
The cytotoxicity of Amhelin and DB were evaluated by
performing a direct cytotoxicity study and by calculating the
cell viability using the CellTiter-Blue R© Cell Viability Assay. The
experiment was performed following the ISO 10993-5 guidelines
[ISO 10993- 5:International Organization for Standardization
[ISO], 2009(E)] in 96 well TCPS microplates.
The CellTiter-Blue R© Cell Viability Assay was used to estimate
the number of viable cells after their exposure to increasing
concentrations of Amhelin and DB for a period of 24 h. The
assay is based on the capability of metabolically active cells,
that is, living cells to convert the redox dye resazurin into a
fluorescent resorufin which is analyzed using a plate-reading
fluorometer. Briefly, on a 96 well TCPS microplate, 100 µL of
a cell suspension containing 104 cells was seeded per well and
incubated in a humidified atmosphere at 5% CO2 in air, at 37
◦C,
for 24 h, to promote cell attachment. On the next day, the cell
media was discarded from each well and 100 µL of increasing
concentrations of each agent, in cRPMI, were added to each
well. The cells were incubated in a humidified atmosphere at
5% CO2, in air, at 37
◦C, for another 24 h. TCPS was used
as negative control and the positive control was composed of
lysed cells after being treated with 2 µL of 9% Triton R© X-
100 (Promega) for 5 min after the 24-hour incubation period.
After the incubation period, the cell supernatant was removed
from the wells and 120 µL of the assay reagent (CellTiter-Blue
diluted with cRMPI) was added to each well and incubated in
a humidified atmosphere at 5% CO2 in air at 37
◦C, for 2 h.
After the incubation period, the supernatant was transferred to
a black 96 well TCPS microplate and the fluorescence was read
at 560 nm. The experiments were performed in two independent
experiments, in quadruplicate (N = 2, n = 4).
Fabrication of Aligned and Bead-Less
PHA Fibers by Electrospinning
The production of PHA fibers was carried out using a custom-
built electrospinning setting composed of a high voltage power
supply, a syringe pump and a rotating steel cylindrical collector.
A 2mL polypropylene syringe (BDDiscarditTM II) equipped with
a 23-gauge steel needle with a blunt tip was used to fabricate
the fibers. The polymer solutions were fed free of air bubbles
to the 2 mL syringe and the fibers were electrospun at a flow
rate of 5 mL/h, with a 14 kV voltage, a needle-to-collector
distance of 14 cm and a rotator speed of 1000 rpm. All fibers
were electrospun to 1 cm diameter glass coverslips. After the
electrospinning process, a drying period of at least 24 h was
used to allow the complete evaporation of any remaining solvent
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from the fibers inside a biological safety cabinet, in ambient
conditions. Subsequently, the fibers were sterilized under the
UV light – UVGI at short-wavelength ultraviolet light (UV-C,
mercury-based lamp emitting UV light of 253.7 nm) for 30 min.
PHAs were dissolved in a 60:40 chloroform/acetone solution at 20
w/v% and the fibers were electrospun directly from this solution.
The surface morphology of the fibers was analyzed by
scanning electron microscopy (SEM). The images were taken
with an acceleration voltage of 5 kV at a 10 mmworking distance.
The analysis was carried out at the Analytical Chemistry –
Center for Electrochemical Sciences (CES) at the Ruhr-University
Bochum, Germany.
Surface Activation of PHA Fibers
The activation of the PHA fibers was carried out using NCO-
sP(EO-stat-PO), in order to promote the covalent coupling
of active agents. For that, PHA was dissolved in a 60:40
chloroform/acetone solution at 20 w/v% and NCO-sP(EO-stat-
PO) was dissolved in acetone at 5 w/v%. Once each solution
was homogeneous, both solutions were mixed and vortexed
vigorously. PHA-NCO-sP(EO-stat-PO) fibers were electrospun
directly from this solution.
Bioactivated fibers were produced by coupling Amhelin and
DB to PHA-NCO-sP(EOstat-PO) fibers. Briefly, using a ratio
of 1:10, Amhelin:NCO-sP(EO-stat-PO), the required amount of
peptide in the form of lyophilized powder was dissolved in a
solution containing 50 µg/mL of DB. The solution was mixed
and vortexed vigorously and fibers were electrospun directly
from this solution.
Using the same conditions described in section “Fabrication
of Aligned and Bead-Less PHA Fibers by Electrospinning,” fibers
were electrospun onto 1 cm diameter glass coverslips. After the
electrospinning process, a drying period of at least 24 h was
used to allow the complete evaporation of any remaining solvent
from the fibers, inside a biological safety cabinet, in ambient
conditions. Subsequently, the fibers were sterilized under the UV
light - UVGI at short-wavelength ultraviolet (UV-C, mercury-
based lamp emitting UV light at the 253.7 nm line) for 30 min.
The set of fibers produced in this study were PHA fibers,
PHA-NCO-sP(EO-stat-PO) fibers and PHA-NCO-sP(EO-stat-
PO)+ Amhelin+ DB fibers.
Water Contact Angle of Activated Fibers
The wettability of the modified fibers was evaluated by the
static sessile drop method using a custom-built contact angle
goniometer. On an average, 30 µL of deionized water was
dropped onto the surface of the fibers with the help of a
syringe. The contact angle was measured using a custom-
built software. Analysis was carried out by the Analytical
Chemistry – Biointerfaces group located at the Ruhr-University
Bochum, Germany. The measurements were performed in
triplicates (n = 3).
Further experiments were carried out with PHA and PHA-
NCO-sP(EO-stat-PO) fibers on glass coverslips using different
pre-conditioning procedures to verify the WCAs measured on
the dried fiber mesh surfaces. The substrates were incubated
in a deionized water-saturated atmosphere at 37◦C for 4 h.
Afterward, WCA measurements were carried out as previously
described but this time as two independent experiments, in
10-fold (N = 2, n = 10).
Anti-adhesive Properties of Activated
Fibers
To evaluate the anti-adhesion properties of the modified fibers,
glass coverslips containing the fibers were placed in a sterile 24-
well polystyrene microtiter plate and each well was inoculated
with 1 ml of a bacterial suspension containing 5 × 105 CFU/mL.
The plate was incubated at 37◦C for 24 h in under static
conditions. After the incubation period, the liquid content from
the wells was removed and each fiber coated glass coverslip was
washed twice with PBS to remove loosely adhered bacterial cells.
Each sample was placed in sterile tubes containing 10 mL of
0.9% sodium chloride and sonicated in a sonication bath for
5 min followed by vortex mixing for 10 s to detach the bacterial
cells. The procedure was repeated three times. The sonicates were
serially diluted in 0.9% sodium chloride and 100 µL of each
dilution were plated onto blood agar plates. After an 18-hour
incubation at 37◦C, the colonies were counted and expressed as
CFU/ml. To complement the test, after the sonication procedure,
the glass coverslips were immersed in an 100% ethanol solution
for 15 min, then stained with a 0.1% safranin-O solution and
incubated for 5 min at room temperature, followed by two-
washing steps with DPBS. The stained-glass coverslips were
dried overnight and imaged using a Panasonic DMC-FZ100. The
experiments were performed in three independent experiments,
in triplicates (N = 3, n = 3).
In vitro Direct Cytotoxicity Evaluation of
Activated Fibers
To evaluate the fiber cytocompatibility, the CellTiter-Blue R© Cell
Viability Assay was performed. Briefly, sterile glass coverslips
containing the modified fibers were placed in a 24-well
polystyrene microtiter plate. A L929 cell suspension containing
5 × 104 cells was seeded per well on top of each glass coverslip
and incubated in a humidified atmosphere of 5% CO2 in air
at 37◦C for 24 h. Following the incubation period, the cell
supernatant was removed and 250 µL of assay reagent (CellTiter-
Blue diluted with cRMPI) was added to each well and incubated
in a humidified atmosphere of 5% CO2 in air at 37
◦C, for
2 h. After the incubation period, 120 µL of each well were
transferred to a black 96-well polystyrene microtiter plate and the
fluorescence was read at 560 nm. Tissue Culture Plastic (TCP)
and non-modified fibers were used as the positive controls and
the negative control was a lysis solution composed of Triton R©
X-100 used to cause cell lysis.
Live-Dead Staining of L929 Murine
Fibroblasts on Activated Fibers
In order to correlate the data obtained via the CellTiter-Blue R© Cell
Viability Assay, a fluorescent cell staining was performed using
a two-color fluorescent staining. Calcein-AM was used to stain
live cells in green and Ethidium homodimer-III (EthD-III) was
used to stain dead cells in red. Living cells are characterized by
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the presence of intracellular esterase activity which can convert
non-fluorescent Calcein-AM to green fluorescent Calcein. On the
other hand, EthD-III can enter the cells that have a damaged
membrane and upon binding to nucleic acids can produce red
fluorescence. After growing the cells on top of themodified fibers,
the culture medium was removed, and each well was washed with
DPBS. A staining solution of 2 µM Calcein-AM/4 µM EthD-
III was prepared in PBS and 480 µL of the staining solution
were added directly to each well. The cells were imaged using an
inverted fluorescence microscope (Olympus IX51).
Statistical Analysis
Experiments were performed on freshly prepared samples and
the results were reported as averages and standard deviations
of these measurements. The statistical analysis was done using
GraphPad Prism 5 version 5.00. Data were compared using
unpaired t-test or a one-way analysis of variance (ANOVA)
Tukey and Dunnett’s test. Differences were considered significant
for p-values lower than 0.05 (p < 0.05).
RESULTS
Antibacterial Characterization of
Amhelin Against Staphylococcus
epidermidis (ATCC R© 35984TM)
As a starting point, the antibacterial properties of Amhelin were
tested against S. epidermidis (ATCC R© 35984TM) by determining
the MIC andMBC, respectively. The bacterial strain was cultured
in the presence of increasing concentrations of Amhelin for
a period of 24 h. The peptide concentration that completely
inhibited visible bacterial growth was determined as the MIC,
while the peptide concentration that resulted in a reduction
of 99.9% of CFUs relative to that in the initial inoculum was
determined as the MBC. The MIC and the MBC of Amhelin
against S. epidermidis (ATCC R© 35984TM) were found to be 6 and
12 µg/mL, respectively (Table 1).
Furthermore, the anti-biofilm properties of Amhelin were
evaluated by quantifying the biofilm biomass that was produced
after a 24-hour bacterial exposure to increasing concentrations
of Amhelin. The biofilm biomass was quantified using a
safranin staining method and the results were expressed as
a percentage of biofilm inhibition compared to a typical
biofilm growth control. With the lowest peptide concentration,
that is 1 µg/mL, biofilm formation was inhibited by only
3%. A more significant effect was observed with a peptide
concentration of 3 µg/mL, where 50% of biofilm formation
was inhibited. With concentrations equal or higher to the MIC,
that is 6 µg/mL, biofilm formation was inhibited by more than
90% (Figure 1).
TABLE 1 | MIC and MBC of Amhelin against S. epidermidis (ATCC R© 35984TM).
Amhelin MIC MBC
S. epidermidis (ATCC R© 35984TM) 6 µg/mL 12 µg/mL
FIGURE 1 | Percentage of inhibition of biofilm formation of S. epidermidis
(ATCC R© 35984TM) by Amhelin when exposed to increasing concentrations of
Amhelin for a period of 24 h. The biofilm growth control is represented by the
column in which no Amhelin was added. The experiments were performed in
three independent experiments, in triplicates (N = 3, n = 3). ∗∗∗p < 0.0001
and n.s indicates no statistical difference when compared with biofilm growth
control.
Dispersin B Is Capable of Detaching
Pre-formed Biofilms
The ability of DB to disperse pre-formed biofilms was tested
against S. epidermidis (ATCC R© 35984TM) by incubating 24-hour
pre-formed biofilms with increasing concentrations of DB for
a period of 24-hours and by quantifying the biofilm biomass
that remained intact after the incubation period, using a safranin
staining method. The results were expressed as a percentage of
biofilm dispersal compared to a typical biofilm growth control.
A similar dispersal activity was observed for all the testing
DB concentrations. With concentrations up until 50 µg/mL,
70% of pre-established biofilms were dispersed. By increasing
the DB concentrations to 100, 200, and 400 µg/mL, pre-
established biofilms were dispersed by 76, 73, and 78%,
respectively (Figure 2).
L929 Murine Fibroblasts Can Grow in the
Presence of Amhelin and Dispersin B
In order to evaluate the cytotoxicity of each of the active agents,
cytocompatibility studies were performed by incubating pre-
adhered L929 murine fibroblasts with increasing concentrations
of either Amhelin or DB for a period of 24 h and by evaluating the
percentage of cell viability after the incubation period. Each graph
shows the percentage of viable L929murine fibroblasts after being
exposed to increasing concentrations of Amhelin and DB for 24 h
in comparison to a cell growth control.
With the results obtained, it was possible to determine the
50% cytotoxicity concentration (CC50), that is, the concentration
resulting in a 50% viability of L929 murine fibroblasts of each
agent as well as to compare the concentrations of the agents at
which high antibacterial performance was obtained with the L929
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FIGURE 2 | Percentage of biofilm dispersal as a result of the incubation of
24-hour pre-established biofilms of S. epidermidis (ATCC R© 35984TM) with
increasing concentrations of DB for 24 h. The biofilm growth control is
represented by the column in which no DB was added. The experiments were
performed in three independent experiments, in triplicates (N = 3, n = 3).
∗∗∗p < 0.0001 and n.s indicates no statistical difference when compared with
biofilm growth control.
cell viability. Amhelin showed a CC50 of 143 µg/mL while DB
showed a CC50 of 134 µg/mL.
The concentrations at which Amhelin showed strong
bactericidal and anti-biofilm properties, that is, 12 and 3 µg/mL
resulted in a L929 cell viability higher than 90%. In the case of
DB, with concentrations up until 50 µg/mL, a cell viability higher
than 70% was obtained (Figure 3).
Fabrication of Polyhydroxyalkanoate-
Based Fibers
The electrospinning process resulted in well aligned and
bead-less fibers with diameters ranging from 500 nm to
2.5 microns (Figure 4).
FIGURE 4 | SEM micrographs of PHA fibers using a 20 w/v% polymer
concentration in a 60/40, chloroform/acetone solution, 14 kV, 5 mL/h flow
rate, needle-to-collector distance of 14 cm and target’s rotation speed of
1000 rpm. Magnification of micrographs on the left-side of 1500× and scale
bar of 20 µm. Magnification of micrographs on the right-side of 500× and
scale bar of 50 µm. Low fiber density samples were used for imaging
purposes only.
Water Contact Angle of Activated Fibers
To evaluate the wettability changes after the functionalization
process, wettability studies were conducted by measuring the
water contact angle of PHA-NCO-sP(EO-stat-PO) fibers, PHA-
NCO-sP(EO-stat-PO) + Amhelin + DB fibers and compared to
the water contact angle of PHAdisks obtained by a solvent casting
method and PHA fibers. PHA disks, PHA fibers, PHA-NCO-
sP(EO-stat-PO) fibers were also pre-incubated in a deionized
water-saturated atmosphere at 37◦C for 4 h to assess the
changes in wettability.
Polyhydroxyalkanoates disks exhibited a water contact angle
of 88o confirming the hydrophobic nature of the material. After
fiber formation, PHA fibers showed a significant increase in
hydrophobicity, with a water contact angle of 124◦. A further
increase in hydrophobicity was observed for PHA-NCO-sP(EO-
stat-PO) fibers which showed a water contact angle of 132◦. On
the other hand, PHA-NCO-sP(EO-stat-PO) + Amhelin + DB
FIGURE 3 | Percentage of cell viability of L929 murine fibroblasts, after growing in the presence of increasing concentrations of Amhelin and DB, for a period of 24 h.
A typical cell growth control and a positive control were considered and are represented as TCPS and cell lysis, respectively.
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FIGURE 5 | Water contact angle of PHA disks, PHA fibers, PHA-NCO-sP(EO-stat-PO) fibers and PHA-NCO-sP(EO-stat-PO) + Amhelin + DB fibers.
FIGURE 6 | Water contact angle of PHA disks, PHA fibers, PHA-NCO-sP
(EO-stat-PO) fibers after incubation in a deionized water-saturated
atmosphere at 37◦C for 4 h.
fibers showed a water contact angle of 62◦ (Figure 5). The pre-
incubation in a deionized water-saturated atmosphere, at 37◦C,
for 4 h, showed that the PHA disks and PHA fibers maintained
their wettability properties, showing water contact angles of 88
and 120◦, respectively. On the other hand, PHA-NCO-sP(EO-
stat-PO) fibers showed a decrease in the water contact angle, to
a value of 80◦ (Figure 6).
In vitro Direct Cytotoxicity Studies
on Activated Fibers
In order to evaluate the cytotoxicity of the functionalized fibers
against mammalian cells, L929 murine fibroblasts were seeded
on the surface of PHA fibers, and on modified PHA fibers for a
period of 24 h. The cytotoxicity of each material was evaluated
by calculating the percentage cell viability after the incubation
period in comparison to the growth control. Additionally, a
fluorescent cell staining was carried out to observe the presence
of live and dead cells on the fibers.
The graph shows the percentage of viable L929 murine
fibroblasts that grew in the presence of the different fibers in
comparison to the cell growth control, TCPS, after an incubation
period of 24 h. A cell viability of 76 and 84% was observed for
PHA and PHA-NCO-sP(EO-stat-PO) fibers, respectively. PHA-
NCO-sP(EO-stat-PO) + Amhelin + DB fibers exhibited a cell
viability of 80% (Figure 7).
The fluorescent micrographs showed the presence of live cells
(green) on the three different types of fibers. Furthermore, the
morphology of the cells grown on the fibers was similar to the
morphology of cells grown on TCPS. PHA fibers and PHA-NCO-
sP(EO-stat-PO) fibers showed a slightly lower cell density as
compared to the remaining types of fibers (Figure 8).
Prevention of Bacterial Cell Adhesion on
Activated Fibers
The anti-adhesive properties of the materials against bacteria was
evaluated by incubating the different fibers with S. epidermidis
(ATCC R© 35984TM) for a period of 24 h. The bacteria that adhered
to the surface of the fibers was removed by sonication and
quantified by plating on blood agar plates. The ability of the
functionalized fibers to prevent bacterial adhesion was expressed
as a percentage by comparing the number of bacteria that adhered
to the surface of unmodified fibers with the number of bacteria
that adhered to the surface of functionalized fibers. Additionally,
after the incubation period, the biofilm biomass that was formed
on the surface of the fibers was stained using the safraninmethod.
The results showed that PHA-NCO-sP(EO-stat-PO) +
Amhelin + DB fibers were able to prevent the bacterial adhesion
by 88% when compared to unmodified PHA fibers. The fibers
containing NCO-sP(EO-stat-PO) only showed similar bacterial
adhesion to that of the PHA fibers (Figure 9).
The staining method showed that PHA fibers and PHA-NCO-
sP(EO-stat-PO) fibers were completely covered by a biofilm
biomass layer while the fibers functionalized with Amhelin+DB
showed the absence of S. epidermidis (ATCC R© 35984TM) biofilms
on their surface (Figure 10).
DISCUSSION
Despite the success of many regenerative medicine strategies,
such as tissue engineering, the problem of contamination
of implantable biomaterials by bacteria persists. Bacteria
can rapidly recognize a foreign material and start its
adhesion process. As the implants get more and more
colonized by bacteria, they start forming a protective
layer which becomes much harder to treat than common
planktonic bacteria. Thus, there is a strong need to mitigate
bacterial adhesion on implants with features such as surface
activated properties that are unfavorable for bacterial
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FIGURE 7 | Percentage of cell viability of L929 murine fibroblasts after its seeding on the surface of PHA fibers, PHA-NCO-sP(EO-stat-PO) fibers and PHA-NCO-
sP(EO-stat-PO) + Amhelin + DB fibers for a period of 24 h. A typical cell growth control and a positive control were considered and are represented by TCPS and cell
lysis, respectively.
FIGURE 8 | Fluorescence micrographs of L929 murine fibroblasts grown on top of PHA fibers, PHA-NCO-sP(EO-stat-PO) fibers and PHA-NCO-sP(EO-stat-PO)
+ Amhelin + DB fibers. The dead cells are represented in red and live cells are represented in green. Magnification of micrographs of 10x and scale bar of 100 µm.
Negative and positive controls are represented by TCPS and cell lysis, respectively.
adhesion but favorable for eukaryotic cell adhesion. The
development of non-cytotoxic and anti-adhesive fiber
meshes was achieved by surface modifying PHA fibers with
bacterial membrane targeting Amhelin and the biofilm
disrupting enzyme DB.
The antibacterial screening of Amhelin showed the
bacteriostatic and bactericidal nature of this AMP. According
to the European Committee on Antimicrobial Susceptibility
Testing (EUCAST) MIC Breakpoints, the most commonly used
antibiotics such as vancomycin, gentamycin and rifampicin
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FIGURE 9 | Percentage of prevention of bacterial adhesion of PHA fibers, PHA-NCO-sP(EO-stat-PO) fibers and PHA-NCO-sP(EO-stat-PO) + Amhelin + DB fibers
after their incubation with S. epidermidis (ATCC R© 35984TM) for a period of 24 h. The experiments were performed in two independent experiments, in triplicates
(N = 2, n = 3). All columns were compared with each other. ∗∗∗p < 0.0001 and n.s indicates no statistical difference.
FIGURE 10 | Safranin staining of bacterial biofilms formed on top of PHA fibers (A), PHA-NCO-sP(EO-stat-PO) fibers (B) and PHA-NCO-sP(EO-stat-PO) + Amhelin
+ DB fibers (C) after a 24-hour bacterial incubation.
have a MIC of 4 mg/mL, 1 mg/mL and 60 µg/mL, respectively,
against some of the most relevant pathogenic bacteria (The
European Committee on Antimicrobial Susceptibility Testing,
2019). Herein, the obtained MIC and MBC values showed
concentrations ranging from 6 to 12 µg/mL, suggesting an
extremely good efficacy at low concentrations. Also, in previous
experiments performed in our lab we observed inhibitory growth
effects against a methicillin-resistant S. epidermidis strain,
showing a potential effect against antibiotic-resistant strains.
Besides the indication of the bacteriostatic and bactericidal
nature of the peptide, promising results were obtained regarding
the anti-biofilm action of Amhelin as in this work, we showed
for the first time that Amhelin had the ability to inhibit
biofilm formation at just 3 µg/mL. The antibacterial screening
showed that with concentrations equivalent to the MIC, biofilm
formation was inhibited between 80 to 90% compared to the
biofilm growth control.
Although the mechanism of action by which AMPs act
against biofilms is not entirely understood, literature suggests
that they interfere with cell communication systems such as
quorum sensing, bind to polysaccharides present in the biofilm
matrix, downregulate genes responsible for biofilm formation
or disrupt and depolarize the membrane potential of biofilm
embedded cells (Yasir et al., 2018). Since Amhelin predominantly
functions by creating pores in bacterial phospholipid bilayers, it
is likely that the anti-biofilm action of the peptide takes place at
a membrane level.
The initial evidence that DB could promote biofilm dispersal
came from studies which showed that the DB mutant (mutant
strain not producing the enzyme) lacked the biofilm dispersal
ability since the cells resulting from the mutant produced biofilm
colonies that were not released to the medium as opposed to
the wild-type strain (Kaplan et al., 2003). Other studies provided
further proof that DB was indeed causing biofilm dispersal as the
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purified enzyme was shown to disperse cells from pre-formed
biofilm colonies of bacteria. The MALDI-TOF mass spectra of
the extracellular polysaccharide, after being digested with DB
showed a high degree of depolymerization (Itoh et al., 2005;
Izano et al., 2007). In addition, it was shown that DB could
act against Staphylococci strains including S. epidermidis and
Staphylococcus aureus (Kaplan et al., 2004; Izano et al., 2008). The
present study confirmed the anti-biofilm activity of DB against
S. epidermidis (ATCC R© 35984TM).
The cytocompatibility evaluation of the different agents
demonstrated a higher selectivity for bacteria over mammalian
cells, as the estimated MICs and MBCs were considerably lower
than the CC50 calculated for L929 murine fibroblasts. The fact
of having such a safe therapeutic window in which the agents
could be used was extremely convenient if the aim was to prevent
bacterial adherence to the maximum without interfering with the
adherence of eukaryotic tissue cells.
Bead formation is a common problem in the electrospinning
process and can affect the quality of the fibers. On the other
hand, non-aligned fibers can affect the process of eukaryotic
tissue cell adhesion due to differences in morphology as aligned
fiber structures resemble the ECM pattern (Bourget et al., 2013).
Beadless and slightly aligned fibers were obtained using the
appropriate spinning conditions and parameters resulting in
fibers with a suitable morphology for cell attachment, spreading
and proliferation.
The surface properties of the materials such as wettability are
known to play a critical role in the process of eukaryotic tissue
cell adhesion, proliferation and differentiation as well as bacterial
adhesion, therefore the wettability of the materials produced
in this study were evaluated and its effect considered in the
process of eukaryotic tissue cell adhesion and bacterial adhesion.
In this study, it was shown that when PHA was processed to
form electrospun fiber meshes, the WCA increased drastically
to values of 120◦ and further increased when processed to form
electrospun fiber meshes along with NCO-sP(EO-stat-PO), to a
WCA of 132◦, granting the materials almost superhydrophobic
properties. It is known that roughness has a great influence on the
water contact angle of a material, and that hydrophobic materials,
when fabricated into highly rough and porous substrates, such
as electrospun fiber meshes, become even more hydrophobic
(Wilson et al., 2005; Yuan and Lee, 2013; Law, 2014). The fact
that similar contact angles for fiber meshes with and without
NCO-sP(EO-stat-PO) were obtained indicates that there was
not a strong tendency for surface segregation, possibly due to
a good miscibility of the additive with the polymer. On the
other hand, and as expected when covalently coupling the active
agents to the fibers, a much lower WCA was obtained. This
evidenced the introduction of hydrophilic groups on the surface
of the fibers, derived from Amhelin and DB, causing the fibers to
have a significantly lower contact angle. Additionally, the results
suggested that these molecules contained enough polar groups
to interact with the charges during the spinning process and
to promote surface segregation. Additionally, when PHA fibers
with and without NCO-sP(EO-stat-PO) were incubated in a
humidified atmosphere for 4 h, the water contact angle remained
the same for the PHA fibers, while it decreased significantly
in the case of the PHA-NCO-sP(EO-stat-PO) fibers. Isocyanate
groups, NCO, are highly moisture-sensitive (Rolph et al., 2016).
The samples containing NCO-sP(EO-stat-PO) when incubated
in a deionized water-saturated atmosphere could have resulted
in the deactivation of the NCO groups causing changes in its
wettability properties caused primarily by water uptake in the
polymer matrix. Further experiments assessing the stability of
PHA-NCO-sP(EO-stat-PO) + Amhelin + DB fibers should also
be considered to evaluate the long-term effect of the materials.
Quantitative cytocompatibility assays revealed cell viability
values higher than 70% for all the electrospun fibers prepared
in this study when compared to the TCPS control, showing
in general, a good cytocompatibility toward L929 murine
fibroblasts. Relatively hydrophilic surfaces are generally preferred
by eukaryotic tissue cells as they tend to promote the attraction
of proteins from the media, such as adhesion of growth factors,
onto their surfaces, hence facilitating the process of cell adhesion
and growth (Lampin et al., 1997; Wilson et al., 2005). For this
reason, when observing the qualitative fluorescent micrographs
it was seen that, the material with the lowest contact angle, that is
PHA-NCOsP(EOstat PO) + Amhelin + DB fibers, 62◦, not only
exhibited a higher cell density, but also showed that the cells were
able to attach and elongate better along the fibers, indicating that
the relatively more hydrophilic properties of the fibers may have
promoted the process of cell adhesion.
The colonization on bioactive fibers by S. epidermidis (ATCC R©
35984TM) was significantly lower than that on the unmodified
PHA fibers and PHA-NCO-sP(EO-statPO) fibers, serving as an
indicator that the covalent coupling of the agents had successfully
conferred anti-adhesive properties to the electrospun meshes.
More specifically, it prevented bacterial adhesion by more than
80% as compared to the unmodified PHA fibers and PHA-
NCO-sP(EO-statPO) fibers. The safranin staining also gave an
indication as to whether the bacteria that adhered to the fibers
was capable of forming biofilms in a 24-hour bacterial incubation
period and the results showed the absence of biofilm biomass
on the bioactivated fibers, suggesting that the materials could
prevent biofilm formation because as a rule of thumb, if bacteria
are unable to adhere to a surface, they are unable to colonize it
and form a biofilm.
As mentioned before, PNAG is responsible for the process of
bacterial adhesion and although the biofilm matrix and chemical
composition of biofilms can vary among bacterial strains, PNAG
has been identified as the main exopolysaccharide present in
Staphylococcal biofilms and other bacterial strains including
E. coli (Wang et al., 2004; Arciola et al., 2015). Given the
results obtained and given that this polysaccharide is present in
the composition of biofilms of major pathogens reiterates the
importance of exploring DB to tackle biofilm formation of other
relevant pathogens.
Another important aspect of this study is that although
still in preliminary stages, it complements the portfolio of
medical materials with antibacterial properties. The chemical
modification of natural and synthetic polymers with either
AMPs or DB has progressively become a strategy to enhance
the performance of implantable materials. For instance, Piras
et al. (2015) performed the encapsulation of frog-skin derived
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AMP, temporin B (TB) into chitosan nanoparticles (CS-NPs)
in which antibacterial action was seen against various strains
of S. epidermidis. In a study conducted by Pavlukhina et al.
(2012) the surface of poly(allylamine hydrochloride) (PAH)
was modified with DB showing anti-biofilm properties against
S. epidermidis. And, in a study conducted by Marcano et al.
(2017) PHA asymmetric membranes containing DB were
developed for wound healing applications showing activity
against S. epidermidis biofilms. DB has also been combined
with other agents such as antibiotic cefamandole nafate and
triclosan that were physically adsorbed to the surface of
polyurethanes resulting in active materials against Staphylococcal
biofilms (Donelli et al., 2007; Darouiche et al., 2009). Despite
encouraging results, the medical community still strives to
develop alternative strategies to prevent biofilm formation on
implantable materials and our study adds a newly developed
3D polymeric structure with unprecedented anti-adhesive and
antibiofilm properties.
Plus, these materials could be used in a range of medical
applications in the form of wound dressings, patches, tissue
engineering scaffolds or medical device coatings. For instance,
osteomyelitis is a condition where bones get infected and
it is one of the most challenging chronic infections found
in patients with open fractures and in patients requiring
orthopedic procedures. Usually, its treatment includes high
doses of antibiotics for long periods of time, surgery and
debridement. As an example, when bacteria infect a bone,
the blood flow of the infected area decreases and necrotic
bone or dead bone is formed, called the sequestrum. In
cases where a sequestrum is formed, surgical debridement is
carried out to remove the sequestrum but often other tissues
are affected and can get damaged such as the periosteum.
The periosteum is a membrane covering the bone structure
which provides nutrients and also serves as a reservoir of
mesenchymal stem cells. If the periosteum is not repaired after
surgery, there is a delay in the healing process accompanied
with lack of nutrients and a much slower and compromised
regeneration process. Therefore, one of the applications of such
fiber meshes could be as a periosteum patch which would
aid in the regenerative process and at the same time prevents
further bacterial contaminations. Additionally, it sometimes
happens that after the removal of the sequestrum, a large
bone defect is present which is usually compensated by
the introduction of intermedullary titanium nails. However,
the prevention of infections is compromised as because of the
absence of vascularization, the antibiotics cannot reach this
area (Berebichez-Fridman et al., 2017). Therefore, one of the
applications of the materials developed here could be as a
coating of such nails.
To achieve this, further in-depth studies are required. For
instance, further characterization steps are needed and are
here suggested as future work. Chemical analysis such as
X-ray photoelectron spectroscopy, atomic force microscopy
or Attenuated total reflectance-Fourier transform infrared
spectrometry should be employed to detect the presence of the
agents on the fibers as well as its spatial topographical distribution
and to quantify the amount of agent present in the fibers.
In vitro screening of the biodegradation profile would also be
very important to evaluate the stability of thematerials and finally
an in vitro release profile of the antimicrobials should also be
investigated. Nonetheless, our proof of principle study showed a
straightforward, one-step procedure to engineer bioactive fiber
meshes based on PHAs and demonstrated that the idea of
combining different novel and innovative antibacterial agents
with different mechanisms of action against bacteria could be
a promising approach toward the development of effective and
efficient anti-biofilm therapies.
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